Law360 (November 27, 2019, 9:24 AM EST) -- Some of the nation's biggest school districts are suing major drug companies over student learning disabilities and other problems allegedly linked to the opioid crisis, portending a potentially enormous new front in the multidistrict opioid litigation.
A complaint filed by Chicago's school district on Nov. 20 accuses a dozen pharmaceutical companies of unlawful opioid sales and seeks damages for expenses related to special education, addiction counseling, campus security and employee health insurance.
The district is the nation's third largest school system, educating 360,000 students and supplying health benefits to 37,000 employees. Its complaint, which was filed directly in the MDL, is...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!